Van Wyk and Grumbach syndrome
| Van Wyk and Grumbach syndrome | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hypothyroidism, precocious puberty, galactorrhea, ovarian cysts |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Hypothyroidism |
| Risks | |
| Diagnosis | Clinical evaluation, thyroid function tests |
| Differential diagnosis | |
| Prevention | |
| Treatment | Thyroid hormone replacement therapy |
| Medication | |
| Prognosis | |
| Frequency | Rare |
| Deaths | |
Van Wyk and Grumbach syndrome is a rare medical condition characterized by hypothyroidism, precocious puberty, and ovarian cysts. It was first described by Jan Van Wyk and Maurice Grumbach in 1960.
Symptoms and Signs[edit]
The most common symptoms of Van Wyk and Grumbach syndrome include delayed growth, menstrual irregularities, and breast development in girls. Other symptoms may include cold intolerance, constipation, dry skin, fatigue, and weight gain.
Causes[edit]
Van Wyk and Grumbach syndrome is caused by long-standing, untreated hypothyroidism. The exact mechanism is not fully understood, but it is believed to involve increased levels of thyroid-stimulating hormone (TSH) stimulating the ovaries, leading to ovarian cysts and precocious puberty.
Diagnosis[edit]
The diagnosis of Van Wyk and Grumbach syndrome is based on the presence of hypothyroidism, precocious puberty, and ovarian cysts. Additional tests may include thyroid function tests, pelvic ultrasound, and magnetic resonance imaging (MRI).
Treatment[edit]
The treatment for Van Wyk and Grumbach syndrome involves treating the underlying hypothyroidism with thyroid hormone replacement therapy. This usually results in resolution of the ovarian cysts and normalization of puberty.
Prognosis[edit]
With appropriate treatment, the prognosis for individuals with Van Wyk and Grumbach syndrome is generally good. However, long-term follow-up is necessary to monitor for potential complications, such as infertility and psychosocial issues related to early puberty.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


